Oral Testosterone Replacement Therapy Market
完整報告名稱與涵蓋範圍
Oral Testosterone Replacement Therapy Market Size, Share & Trends Analysis Report, By Product Type (Oral Testosterone Undecanoate Capsules, Other Oral Testosterone Formulations), By Indication (Primary Hypogonadism, Hypogonadotropic Hypogonadism, Age-Related and Other Testosterone Deficiency), By Distribution Channel (Retail Pharmacies, Online and Telehealth Pharmacies, Hospital Pharmacies), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The oral testosterone replacement therapy market covers prescription oral formulations, principally self-emulsifying testosterone undecanoate capsules approved since 2019, used to treat hypogonadism in adult men, together with the prescribing channels through which they are dispensed. Injectable, transdermal, nasal and implantable testosterone products are excluded from revenue but analysed as the incumbent share pool from which oral products draw patients.
Oral products have shifted the category by removing transference risk, injection burden and gel application while providing predictable pharmacokinetics that avoid the liver toxicity of earlier oral androgens. Their growth is supported by the resolution of long-standing cardiovascular safety questions through a large outcomes trial, by the expansion of direct-to-consumer men's health telehealth platforms that favour oral dosing, and by lifecycle strategies including label updates on blood pressure monitoring and combination with fertility-sparing regimens. Pricing relative to generic injectables, payer step-therapy requirements and the prospect of generic oral undecanoate entry constrain long-run margins.
The United States is by far the largest market given prescribing patterns and telehealth penetration, followed by Europe and Australia, with growth in Latin America and the Middle East. Competition involves specialty pharmaceutical franchise owners, generic manufacturers preparing follow-on products and telehealth prescribers integrating oral testosterone into subscription models.
The InsightAce study includes revenue forecasts in US$ for all product type, indication, distribution channel and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oral Testosterone Replacement Therapy Market Snapshot
Chapter 4. Global Oral Testosterone Replacement Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. Oral Testosterone Undecanoate Capsules
5.2.2. Other Oral Testosterone Formulations
Chapter 6. Market Segmentation 2: By Indication Estimates & Trend Analysis
6.1. Indication & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
6.2.1. Primary Hypogonadism
6.2.2. Hypogonadotropic Hypogonadism
6.2.3. Age-Related and Other Testosterone Deficiency
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
7.2.1. Retail Pharmacies
7.2.2. Online and Telehealth Pharmacies
7.2.3. Hospital Pharmacies
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Urology and Endocrinology Clinics
8.2.2. Primary Care and Men's Health Clinics
Chapter 9. Oral Testosterone Replacement Therapy Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Halozyme Therapeutics, Inc. (Antares Pharma)
11.2. Marius Pharmaceuticals, LLC
11.3. Tolmar, Inc.
11.4. Clarus Therapeutics (Legacy Jatenzo Franchise)
11.5. Endo, Inc.
11.6. AbbVie Inc.
11.7. Acerus Pharmaceuticals (Aytu BioPharma)
11.8. Bayer AG
11.9. Besins Healthcare
11.10. Hims & Hers Health, Inc.
11.11. Ro (Roman Health)
11.12. Lupin Ltd.
11.13. Sun Pharmaceutical Industries Ltd.
11.14. Cipla Ltd.
11.15. Perrigo Company plc
圖表清單 List of Tables & Figures
Table 1. Global Oral Testosterone Replacement Therapy Market Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global Oral Testosterone Replacement Therapy Market Segmentation and Scope Overview
Table 2. Global Oral Testosterone Replacement Therapy Market Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 2. Global Oral Testosterone Replacement Therapy Market Share by Product Type, 2026 & 2035
Table 3. Global Oral Testosterone Replacement Therapy Market Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 3. Testosterone Replacement Share Shift by Dosage Form, 2026-2035
Table 4. Global Oral Testosterone Replacement Therapy Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Telehealth and Direct-to-Consumer Prescribing Channel Growth for Oral Testosterone
Table 5. Global Oral Testosterone Replacement Therapy Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific Oral Testosterone Replacement Therapy Growth Opportunity Analysis
Table 6. North America Oral Testosterone Replacement Therapy Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key Oral Testosterone Replacement Therapy Market Participants
Table 7. Europe Oral Testosterone Replacement Therapy Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global Oral Testosterone Replacement Therapy Market
Table 8. Asia Pacific Oral Testosterone Replacement Therapy Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Cardiovascular Safety Evidence and Its Effect on Prescriber Confidence
Table 9. Strategic Developments of Leading Oral Testosterone Replacement Therapy Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們